EGFR Positive UK
Home News Contact
Donate
Our Mission Our Early Diagnosis Campaigns Real Life Stories Who We Are 5 Years of EGFR+ UK! Inclusion and Diversity Our Policies Annual Report 2024/25
What is EGFR? Treatment Options Glossary
EGFR+ UK Conferences 2025/6 EGFR Good Practice Guide Crisis support Videos Mental Wellbeing Support Clinical Trials Travelling with Lung Cancer Other Resources
Donating Fundraising
Home About Us Our Mission Our Early Diagnosis Campaigns Real Life Stories Who We Are 5 Years of EGFR+ UK! Inclusion and Diversity Our Policies Annual Report 2024/25 About EGFR What is EGFR? Treatment Options Glossary Patient Support EGFR+ UK Conferences 2025/6 EGFR Good Practice Guide Crisis support Videos Mental Wellbeing Support Clinical Trials Travelling with Lung Cancer Other Resources NewsContact Get Involved Donating Fundraising
EGFR Positive UK
Offering hope & learning for those with EGFR+
Donate
 

News

 
news-purple.jpg
A New Patient Alliance - ODLC
A New Patient Alliance - ODLC
EGFR PositiveAugust 7, 2022
EGFR Positive publication in Oncology and Therapy journal
EGFR Positive publication in Oncology and Therapy journal
EGFR PositiveMarch 26, 2021
UKLCC Covid Matters Report
UKLCC Covid Matters Report
EGFR PositiveOctober 31, 2020
Osimertinib approved for untreated EGFR mutation-positive NSCLC
Osimertinib approved for untreated EGFR mutation-positive NSCLC
EGFR PositiveOctober 14, 2020
Osimertinib approved for treating EGFR mutation positive NSCLC
Osimertinib approved for treating EGFR mutation positive NSCLC
EGFR PositiveOctober 14, 2020
Adjuvant Osimertinib in Early-Stage EGFR-Positive NSCLC
Adjuvant Osimertinib in Early-Stage EGFR-Positive NSCLC
Guest UserJune 10, 2020
UKLCC Early Diagnosis Matters Report
UKLCC Early Diagnosis Matters Report
EGFR PositiveFebruary 4, 2020
Osimertinib in Untreated EGFR-Mutated Advanced Non–Small-Cell Lung Cancer
Osimertinib in Untreated EGFR-Mutated Advanced Non–Small-Cell Lung Cancer
EGFR PositiveNovember 25, 2019
EGFR Positive UK first meeting
EGFR Positive UK first meeting
Guest UserNovember 16, 2019
Newer

The latest news

News
EGFR+ UK One-Day Conferences
Aug 21, 2025
EGFR+ UK One-Day Conferences
Aug 21, 2025
Read More →
Aug 21, 2025
2025 Members' Survey now open!
Aug 2, 2025
2025 Members' Survey now open!
Aug 2, 2025
Read More →
Aug 2, 2025
EGFR+ UK at BTOG!
May 10, 2025
EGFR+ UK at BTOG!
May 10, 2025
Read More →
May 10, 2025
Run the London Marathon for EGFR+ UK - Appy Now!
May 1, 2025
Run the London Marathon for EGFR+ UK - Appy Now!
May 1, 2025
Read More →
May 1, 2025
Thank You to Natasha as She Changes Role
Mar 31, 2025
Thank You to Natasha as She Changes Role
Mar 31, 2025
Read More →
Mar 31, 2025
A New First-Line Option for EGFR+ Lung Cancer
Mar 27, 2025
A New First-Line Option for EGFR+ Lung Cancer
Mar 27, 2025
Read More →
Mar 27, 2025

EGFR+ UK are proud members of Lung Cancer Europe

 
 

NEW! Follow us on Bluesky 🦋

 
 
View fullsize Thanks to Kate Wells from the @ruthstraussfoundation for joining us for our recent Meet the Expert session on talking to children about a lung cancer diagnosis. 💜 Kate shared compassionate, practical advice on how to approach these conversations wi
View fullsize 💚 Thank you to everyone who joined us in Bristol for our second L EGFR+ UK one-day conference. We’ve had great feedback from the day and we’re delighted to confirm we’ll be back in Bristol on 14 October 2026. Next up: 📍 Edinburgh
View fullsize News from ESMO 2025: 
Zipalertinib is being studied for people with advanced EGFR-positive lung cancer who have active brain metastases - specifically EGFR exon 20 insertions or other uncommon EGFR mutations.   Early results from the REZILIENT2
View fullsize

Medical Disclaimer

The contents of this website are for informational purposes. The content is NOT a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of a qualified professional with any question you have regarding a medical condition. EGFR Positive UK does not endorse any companies, products or opinions that may be mentioned on this website.

 

© 2025 EGFR POSITIVE UK - Charity nº 1189722


PRIVACY POLICY

COOKIE POLICY